• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Data Market
Data News
Data Stocks
  • Data Market
  • Data News
  • Data Stocks

Big Data Analytics in the Healthcare Sector to Grow Over $34.27 Billion by 2022

Morag Mcgreevey
Feb. 15, 2016 08:41AM PST
Data Investing

RESEARCH and MARKETS has announced the release of a new report, “Global Big Data in Healthcare — Estimates & Forecast, 2015-2022.” The report states that Big Data Analytics in the healthcare sector is estimated to grow over $34.27 billion by the end of 2022.

RESEARCH and MARKETS has announced the release of a new report, “Global Big Data in Healthcare — Estimates & Forecast, 2015-2022.” The report states that Big Data Analytics in the healthcare sector is estimated to grow over $34.27 billion by the end of 2022.
According to the press release:

Several forces are triggering the boost in the overall demand for Big Data integration in the healthcare industry. Governmental agencies are encouraging the use of Big Data in the healthcare sector. The Department of Health and Human Services (HHS) under the Health Data Initiative (HDI) is starting to release data from agencies like the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) in order to access public data of patients for clinical trials and other research activities.
The healthcare industry is in a period of rapid change. Advancements in the fields of genetics, biomedical, and information technology are paving a way towards effective personalized treatments in accordance to the individual characteristics of the patients.
Exploiting these opportunities requires effective usage of Big Data. Over time, healthcare data has been created and accumulated continuously through patient records, radiology images, clinical trials and genomic sequences.

Click here to read the full press release.


 
clinical-trials big-data food-and-drug-administration
The Conversation (0)

Go Deeper

AI Powered
Scientist pouring blue liquid from a test tube into a flask in a lab.

Biotech Market Forecast: Top Trends for Biotech in 2026

Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

Latest News

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Data Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES